Member Info for GreggsStottie

Yes, but that is just the covid play and they will have the scope to increase from 100,000 over time so think this could get to £20-£25 a share in the medium term. COPD application is worth c.£5 per share alone.

If and when a big Pharma Co come along they are likely to have to pay a premium for instant revenue and bottom line profit.

Hoping for a nice retirement!
All the best

21-Oct-21 15:44:43 174.00 25,000 Buy* 172.60 174.00 43.50k

Institutional buys perhaps starting to be drawn out! This is going to re-rate over a few weeks, it just has to as the P3 news sinks in.

Next stop £9.90....but likely to have to wait until Q1 2022 for that! Not that long a wait from here!

GL all....

Colin's last buy was at 53p.....cant see him accepting a derisory 60p to be honest.

The POTENTIAL of ODX is fantastic, however we need the approvals 1st. It does seem to be taking an age, but that's investing and that's sometimes how it goes.

I wont be selling some until the approvals come and the re-rate is in play. I think £2 to £3 is likely should everything come off as we think it will. At worst this should swing up above £1....so easy money to be made for the patient investor.

Lets see what comes out of the upgraded JORK, and signing over of the leases. LEGALLY BINDING speaks volumes.....and we have the best lawyers in the business on this.

It is painful seeing the sp stagnate, however in the cold light of day, I look at the RNS's and reaffirm my belief in the bod, and the research the II's will have done at 26p, 26.5p and 29p. The recent placing volume was lowered to suit the BOD's funding requirements. They could have easily upped this, but they didn't.

I think that anything below 26p is a gift - so I have been buying when I can. I am lucky that my average is in the single digits, however it matters not. The writing is on the wall, and it just needs a bit more patience. I am confident that the bod are negotiating hard in the background to secure their future wealth (and ours as a result).

Watching the daily fluctuations is doing my head in! lol...

I see NCYT did 6p to £12....does this mean it cant happen again? They had a perfect storm.....perhaps we have as well. I am not saying £12 for clarity, I am just saying that the potential here is in the pounds rather than pence.

Only those holding on the day of reckoning will be rewarded. Lets hope that is not too far away, so I can get some work done!

...and still below the recent placing. An absolute bargain imo.

2022 is going to be a strong year for SNG....just wait until approval and 1st orders are placed, then we will have fireworks! Until then, I continue to hold my shares. You don't get to P3 without substance and safety, which we have in droves.

The biggest cost saving for governments/organisations is to reduce length of hospitalisation for patients.

So, if you are going to get an approval, it has to be commercially beneficial to someone. Saving several days in hospital is very expensive....we prove wd reduce this in our trials (again) and its game on.

Treating people at home is less costly, and less of a big ticket win.

It's great to watch this unfold from the 35p days....

The moving of share price is not ideal (paper gains/losses) but the business has transformed since last year. I for one am grateful for the share price being this low. It presents a great opportunity for the patient investor to reap long term gains.

Being able to top up at 16-24p has been something I thought impossible a year ago.....so depends entirely on your strategy and risk profile.

Yes, but if you are happy and well off I would say that should make you even happier through a feeling of security.

Its complicated by the transfer of ownership of the JV areas...so suspect the notification of Ownership of the jv areas and Jorc will be notified simultaneously.

I hope shortly is next week! Followed by confirmed offers in early Nov, shareholder's meetings in Early December and completion of sale in early 2022.

Like most, completion by Christmas would be preferable, but I can wait...

I blooming hope so....was hoping to switch some into GGP...but that looks to be off to the races now!

Topped up again for the 1000'th time on Weds...like most waiting for the end game, but it is painful. We can only use what we see to make a decision...the kippers are flying in at levels below 2 recent placings and we are now fully funded near term.

GL all...

I can only see a green box.....so has no effect. The filter box is a great thing to behold.

They are busy doing something....we "mushrooms" can only take the hints and make a decision as to whether this will have an impact on the future revenues of ODX.

Personally, I take it positively. I hope it will be transformational...but that's my choice.

I believe this will eventually translate into the share price. Frustrating as the wait is, I think it will come and I hope it is pre xmas, hopefully sooner...!

That should have said...
Funny to see yet more pics of Alva...the next set of results should tell us more and hopefully some interesting targets being hit...I.e. 2m cassettes per week, payments being made, cashflow solid...

I am really looking forward to hearing we have achieved approval in the EU...then game on. It does seem to be taking an age!!!

...and I hear there is a shortage of LFT's...pharmacies are offering pcr tests as a result.

Once the approvals come I think it's safe to say we will be in the £££'s.

Funny to see yet more pics of Alva...the nexf set of results should te us more interesting kids being hit...

All the best...

Misstestes, I would say that your last post was an attack...when you say "are you drunk or delilusional?" That is pretty pointed don't you think....interesting that you have only been on the LSE for 1 month.....you posted this on the Prem board recently..."I would much rather if individuals kept reminding us what we DO have and whats yet to come!"

So, remind us of what we DO have and what's yet to come?

Is mis-testes a euphonism for boll-ocks???

Ending the fsp, saying we are focused on 1 offer for substantially all the assets... genius...."yeah, we not being mucked around. You either pay up or leave the bidding room. We know what we have and it's value, it's up to you guys. Bye."

Hey, guess what....they came back and showed their cards....

I really love negotiation, when yoh hold all the aces.

All the stars are aligning....bidding war will ensue once the JORK is out.

Look forward to the rerate coming "shortly"

GL all...

Partnering later, once a drug is approved will add substantial value to the investment. I for one am more than happy to wait for the £25 share price in 2022. If we had partnered earlier you could take 75% off that at least....

When you have the funds, the capability and knowledge why give away all your hard work for a small % of its true value?

I do hope the sp drops, so I can buy more. I'm here for the end game, not just the pre-dinner drinks.

USA is 25% of the global covid cases. This is a huge market for our drug, and at premium prices. The £25 a share valuation is still possible. Let's get to £9.90 first though...

We have just a few months to wait for completion of patient enrollment. Within 6 months I will know if I can retire early.

GL all.

All the stars are starting to align...they must have good data already. You don't prepare for Commercial launch if you think the trials are going to fail.

The highlight for me is the application as a "broad use antiviral." Plusthe reiteration of potential to scale up to 100,000 treatments a month. £££££££££££££££££££££££££££££££££££££££££££££££££££

Onwards and upwards....a great RNS imo.